3D bioprinting tissues

Lab-grown tissue innovations are gaining investment momentum across the United States as regenerative medicine moves from experimental science toward structured commercialization. Venture capital firms, strategic pharmaceutical partners, and public funding agencies are increasingly backing companies developing engineered tissues for therapeutic transplantation, drug testing, and disease modeling. This capital influx reflects confidence in platform scalability, regulatory … Read more